ATRX and glioblastoma: The results of the Kaplan-Meier analysis revealed that patients with GBM harboring an ATRX mutation exhibited a significantly prolonged survival time (log-rank test, P = 0.003), compared to those with wild-type ATRX (Fig. 2A).